Zahidul Mondle

Zahidul Mondle is a seasoned professional in the biopharma and gene therapy sectors, currently serving as Vice President of Business Development for Cellomics Technology, LLC, focusing on R&D and manufacturing solutions for viral vectors and Cell & Gene Therapy products and services. Previously, Zahidul Mondle held roles at Cytiva and GE Healthcare as a Lead Business Development Specialist and Business Development Specialist, respectively, developing customized biopharma solutions for the pharmaceutical industry. Earlier experience includes positions at Pfizer, Rapid Pathogen Screening, Neogen Corporation, and Michigan State University, where expertise was established in vaccine development, clinical diagnostics, and research on respiratory and genetic diseases. Zahidul Mondle holds an MBA in Business Globalization from the University of Maryland University College, a Ph.D. in Biochemistry from Ehime University, and a Bachelor's Degree in Biochemistry from the University of Dhaka.